Enzyme Therapies
Some alternative medicine practitioners claim that digestive enzyme supplements not only relieve digestive problems, such as ulcers and food allergies, but also strengthen the immune system, improve circulation, ease sore throat pain, aid weight loss, and relieve hay fever, ulcers, and rheumatoid arthritis. Proponents also claim that certain enzymes remove a protective coating from cancer cells, allowing white blood cells to identify and attack them.
"Enzymes are life", as many like to say. Besides digesting food, the body uses them in creating energy, fighting disease and for thousands of other activities within the body. Human biochemistry is all about converting one chemical substance into another - mostly with the help of enzymes. In fact, Edward Howell in his important book "Enzyme Nutrition" claims we are by mass 80% enzymes.
Certain proteolytic enzymes (protein digesting enzymes) are used to digest a cancer cell's tough protein coating, or outer cell wall. This is a remarkable technique cancer cells have developed to protect themselves from our immune system. In short - they hide. Protein digesting enzymes eat away at this outer wall which leaves the cell vulnerable to the immune system's so-called NK cells (also called leukocytes or white blood cells). The NK cells will then recognize the cell as dangerous and defective and go to work dissolving it.
Enzymes are usually abundant in raw foods. But the modern diet for decades has been focused on cooked and processed foods. As critical as they are to all life processes, enzymes are fragile and easily destroyed by .....
- Cooking food over 115 degrees (Approx.)
- Pasteurization
- Commercial food processing
- Food Irradiation
- Carbonated beverages.
In this era of fast approaching
changes in cancer treatment, enzyme therapy is finally gaining serious
mainstream recognition. For example, the work of physician Nicholas Gonzalez MD
of New York is now being assessed in a large National Cancer Institute/National
Institutes of Health (NCI/NIH) funded clinical trial conducted through New
York’s Columbia University.
Much of Dr. Gonzalez's interest in alternative approaches began in his second
year of medical school, when he was introduced to the cancer treatment used by
William Donald Kelley, DDS, a dentist active in the cancer underground from the
1960’s through the 1980’s. (More about Dr. Kelley to follow.) Kelley had
pioneered a method of using enzymes in combination with nutrition to cure
himself of pancreatic cancer.
Amazingly, enzyme cancer therapy dates back to the early 1900s and the theories of Scottish biologist, John Beard. A teacher at the University of Edinburgh, Beard proposed that the digestive function and pancreatic enzymes represent the body’s main defense against cancer. To his surprise, Beard found that human infant placenta cells look and behave like cancer cells. However, the placenta stopped growing and acting like an invading tumor-like tissue, when the baby's pancreas became activated about it's 4th month within the mother. He hypothesized that the fetus started producing enzymes to control placenta and that without this production the placenta would continue growing and ultimately kill the mother and baby.
Beard took this work to yet another
level, believing that all tumors throughout the body arose from misplaced
placenta cells, which had been deprived of proper control. These cells were
thought to be left over from early embryonic stages in both males and females
and were kept under control by circulating pancreatic enzymes throughout
adulthood. However, these cells can quickly grow out of control should the
pancreas fail to manufacture or release adequate amounts of proteolytic
enzymes. In 1911, Beard published a monograph of his work, entitled
The Enzyme Therapy of Cancer. Although his
peers scoffed at him, his work is now recognized as being essentially correct.
Today histologists and molecular biologists have identified Beard’s misplaced
placental cells in every organ. Today, however, they are called stem cells.
Unfortunately, after Beard’s death in 1923, his amazing insights were ignored
and forgotten. Dr. Gonzalez has found that orally ingested pancreatic enzymes
are acid stable, can pass into the small intestine and be absorbed through the
intestinal walls and enter into the blood stream. It is now clear that
pancreatic proteolytic (protein digesting) enzymes have a profound
cancer-fighting effect. If only today's cancer oncologists (MDs) would recognize
this and use them - after 90+ years of being ignored!
The pancreas has the responsibility for producing these much-needed enzymes not available from our food anymore, but can become weakened and overwhelmed in the cancer fighting process. Note that proper dietary minerals are essential for the pancreas to manufacture enzymes. Research in developing new forms of cancer-fighting enzyme preparations has been going on for many years. Meanwhile, according to Dr. Hugh Smith of the Life Sources Educational Library, the way to get rid of the "slime coating", as some call it, protecting cancer cells is to use large doses of plant and/or animal enzymes - he cites bromelain and pancreatin. Again, this allows an access point for the immune system to recognize and attack the cancer cells.
More about Dr. William Kelley DDS: A pioneering dentist & scientist, he became a cancer researcher/ therapist after healing himself of terminal cancer with diet and the pancreatic enzymes trypsin and chymotrypsin. He successfully treated thousands of cancer patients who sought him out over the years. And along the way was endlessly harassed and persecuted by "medical authorities" for practicing medicine without a license. No matter that he was achieving great success curing cancer. More later on this wonderful medical pioneer.
Alternative care practitioners and clinics all have their favorite brand of enzyme preparations of one kind or another in fighting cancer. Wobenzyme (or Wobenzym), a heavily researched German formulation, is a very popular non-prescription choice in Europe. It is available in the USA online. See www.healingedge.net/store/more_wobenzyme.html for a good write-up (Note: 800 TB means 800 tablets).
Another of the world's best preparations is called VitalZyme by World Nutrition. Perhaps this blend of several key enzymes is the strongest formula today, having the powerful serapeptase as it's dominant protein digesting enzyme. See www.worldnutrition.info.
Many full-spectrum enzyme preparations are available in health food stores today. Try www.sonlight.net for excellent information on enzymes and their importance.
Megazyme Forte® is still another enzyme preparation many cancer patients use. See www.medresproducts.com for a source. Another is called Omnizyme Forte®. See www.home.bluegrass.net/~jclark/omnizyme.htm.
There is no one single enzyme formula among those above vastly superior to the others. All of the above are good. The most important thing of all is that they get used.
SPECIAL NOTE
Although this Guide concerns alternative approaches to cancer treatment, there is a conventional pharmaceutical drug that has proved helpful in removing the tough protective coating around cancer cells: Heparin, a harmless blood thinner used by many elderly people. Most MDs are not yet aware of its value against cancer. For those pursuing treatment by conventional MDs, be sure to show your doctor the following scientific references.
1: Braz J Med Biol Res 2001 Jun;34(6):711-7
P-selectin, carcinoma metastasis and heparin: novel mechanistic connections with therapeutic implications.
Varki A, Varki NM. Departments of Medicine and Pathology, Cancer Center and Glycobiology Research and Training Center, University of California-San Diego, 9500 Gilman Drive, La Jolla, CA 92093-0687, USA. avarki@ucsd.edu
Metastasis is a multistep cascade initiated when malignant cells penetrate the tissue surrounding the primary tumor and enter the
bloodstream. Classic studies indicated that blood platelets form complexes around tumor cells in the circulation and facilitate metastases. In other work, the anticoagulant drug heparin diminished metastasis in murine models, as well is in preliminary human studies. However, attempts to follow up the latter observation using vitamin K antagonists failed, indicating that the primary
mechanism of heparin action was unrelated to its anticoagulant properties. Other studies showed that the overexpression of sialylated fucosylated glycans in human carcinomas is associated with a poor prognosis. We have now brought all these observations together into one mechanistic explanation, which has therapeutic implications. Carcinoma cells expressing sialylated fucosylated mucins can interact with platelets, leukocytes and endothelium via the selectin family of cell adhesion molecules. The initial organ colonization of intravenously injected carcinoma cells is attenuated in P-selectin-deficient mice, in mice receiving tumor cells pretreated with O-sialoglycoprotease (to selectively remove mucins from cell surfaces), or in mice receiving a single dose of
heparin prior to tumor cell injection. In each case, we found that formation of a platelet coating on cancer cells was impeded, allowing increased access of leukocytes to the tumor cells. Several weeks later, all animals showed a decrease in the extent of established metastasis, indicating a long-lasting effect of the short-term intervention. The absence of obvious synergism amongst the three treatments suggests that they all act via a common pathway. Thus, a major mechanism of heparin action in cancer
may be inhibition of P-selectin-mediated platelet coating of tumor cells during the initial phase of the metastatic process. We
therefore suggest that heparin use in cancer be re-explored, specifically during the time interval between initial visualization of a primary tumor until just after definitive surgical removal.
Obligatory Legal Disclaimer: This research information is provided for personal educational purposes only, and does not constitute a medical claim for any product of any nature whatsoever. Consult a qualified healthcare practitioner for the diagnosis and treatment of any disease, ailment or medical condition. These Statements have not been approved by the FDA.